Gregory M Weinhoff's Net Worth
$57.1 Million
Who is Gregory M Weinhoff?
Gregory M Weinhoff has an estimated net worth of $57.1 Million. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, AMICUS THERAPEUTICS INC, and Axovant Sciences Ltd..
SEC CIK
Gregory M Weinhoff's CIK is 0001400975
Past Insider Trading and Trends
2021 was Gregory M Weinhoff's most active year for acquiring shares with 3 total transactions. Gregory M Weinhoff's most active month to acquire stocks was the month of January. 2007 was Gregory M Weinhoff's most active year for disposing of shares, totalling 16 transactions. Gregory M Weinhoff's most active month to dispose stocks was the month of May. 2021 saw Gregory M Weinhoff paying a total of $200,000.00 for 1,288,641 shares, this is the most they've acquired in one year. In 2008 Gregory M Weinhoff cashed out on 50,000 shares for a total of $850,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Centessa Pharmaceuticals plc (CNTA) Snapshot price: $7.59
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.43% | -11.74K |
$9.03 | -$106,030.26 | 253.37K |
Jun 30
| |||
Form 4
| -4.24% | -11.74K |
$11.30 | -$132,684.60 | 265.11K |
Mar 31
| |||
Form 4
| +7.68% | 19.76K |
$8.19 | -$94,135.86 | 276.85K |
Feb 1
| |||
Form 4
| -4.37% | -11.74K |
$7.96 | -$93,466.32 | 257.1K |
Dec 31
| |||
Form 4
| -4.18% | -11.74K |
$6.47 | -$75,970.74 | 268.84K |
Sep 30
| |||
Form 4
| -4.02% | -11.74K |
$5.90 | -$69,278.97 | 280.58K |
Jun 30
| |||
Form 4
| -2.76% | -8.29K |
$3.90 | -$32,338.80 | 292.32K |
Mar 31
| |||
Form 4
| +34.55% | 77.2K |
—
|
—
| 300.62K |
Feb 1
| |||
Form 4
| -4.70% | -11.28K |
$4.25 | -$47,948.50 | 228.72K |
Sep 30
| |||
Form 4
| -2.21% | -5.30K |
$3.10 | -$16,439.30 | 234.7K |
Dec 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -3.71% | -8.90K |
$4.00 | -$35,629.04 | 231.1K |
Sep 30 - Oct 3
| |||
Form 4
| +2,300.00% | 230K |
—
|
—
| 240K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 10K |
$20.00 | $200,000.00 | 10K |
Mar 4 - Jun 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $12.945
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.37% | -50.00K |
$17.00 | -$850,000.00 | 2.06M |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +1,481.43% | 1.98M |
—
|
—
| 2.11M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.475
Principal Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||